Claris divests 80 pc stake in infusion biz for Rs 1,050 cr
As part of the deal, two of the out of the five plants of Claris would be transferred to joint venture firm – Claris- -Otsuka, the company said.
The JV will co-brand its products in India and across emerging markets utilising the manufacturing and marketing competence of Claris, it added.
Shares of Claris Lifesciences today closed at Rs 264.55 on the BSE, down 3.75 per cent from its previous close.
Be the first to comment.